Notice2023-07997
Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 17, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC). CHAC consists of 18 experts in fields associated with public health, epidemiology, laboratory practice, immunology, infectious diseases, substance use disorder, behavioral science, health education, healthcare delivery, state health programs, clinical care, preventive health, medical education, health services and clinical research, health equity, and healthcare financing, who are selected by the Secretary, HHS.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 73 (Monday, April 17, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Pages 23424-23425]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07997]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the CDC/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership on the CDC/HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and Treatment (CHAC). CHAC consists
of 18 experts in fields associated with public health, epidemiology,
laboratory practice, immunology, infectious diseases, substance use
disorder, behavioral science, health education, healthcare delivery,
state health programs, clinical care, preventive health, medical
education, health services and clinical research, health equity, and
healthcare financing, who are selected by the Secretary, HHS.
DATES: Nominations for membership on CHAC must be received no later
than October 1, 2023. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#1d737e75756e696d6d7271747e645d7e797e337a726b"><span class="__cf_email__" data-cfemail="5d333e35352e292d2d3231343e241d3e393e733a322b">[email protected]</span></a>
with the subject line ``CHAC 2024 Nomination.''
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, Office of Policy, Planning, and Partnerships, National Center for
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-3423; Email: <a href="/cdn-cgi/l/email-protection#7538361a1b111c01351611165b121a03"><span class="__cf_email__" data-cfemail="c68b85a9a8a2afb286a5a2a5e8a1a9b0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Secretary, Department of Health and
Human Services (HHS), and by delegation the Director, Centers for
Disease Control and Prevention (CDC), and the Administrator, Health
Resources and Services Administration (HRSA), are authorized by the
Public Health Service Act to: (1) conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases and other impairments; (2) assist states and their
political subdivisions in preventing, suppressing, and treating
communicable diseases and other preventable conditions and in promoting
health and well-being; (3) assist public and non-profit private
entities in preventing, controlling, and treating sexually transmitted
diseases (STDs), including the human immunodeficiency virus (HIV); (4)
improve health and achieve health equity through access to quality
services and a skilled health workforce and innovative programs; (5)
support healthcare services to persons with or who experience risk for
HIV, viral hepatitis, and other STDs; (6) advance the education of
health professionals and the public about HIV, viral hepatitis, and
other STDs; and (7) adolescent and school health as it pertains to HIV,
viral hepatitis, and STDs.
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHAC) meets at least two times each calendar
year, or at the discretion of the Designated Federal Officers in
consultation with the CHAC co-chairs.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on federal workgroups or prior
experience serving on a federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships. The
CHAC charter stipulates that the Committee must include at least four
members who are persons with HIV. The Committee may also include
representation from persons with lived experience, such as those who
have experienced viral hepatitis, STDs, and drug use; state and local
health and education agencies; HIV/viral hepatitis/STD community-based
organizations; and the ethics or faith-based community.
Committee members are Special Government Employees (SGEs),
requiring the filing of financial disclosure reports at the beginning
of
[[Page 23425]]
and annually during their terms. Individuals who are selected for
appointment will be required to provide detailed information regarding
their financial interests and, for example, any work they do for the
federal government through research grants or contracts. Disclosure of
this information is required in order for CDC ethics officials to
determine whether there is a conflict between the SGE's public duties
as a member of CHAC and the SGE's private interests, including an
appearance of a loss of impartiality as defined by federal laws and
regulations, and to identify any required remedial action needed to
address the potential conflict.
CDC and HRSA review potential candidates for CHAC membership when a
vacancy arises and provide a slate of nominees for consideration to the
Secretary of HHS for final selection. CDC and HRSA each publish a
Federal Register notice and will be using a joint process to nominate
nominees on a rolling basis; thus, applications received by CDC will be
shared with HRSA for consideration. Therefore, potential candidates
need only apply in response to one of the Federal Register notices. HHS
notifies selected candidates of their appointment near the start of the
term in December 2024, or as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year. Candidates should submit the
following items:
[ssquf] A letter of interest or personal statement from the nominee
stating how the nominee's expertise would inform the work of CHAC
[ssquf] A biographical sketch of the nominee (500 words or fewer)
[ssquf] Current curriculum vitae or resume, including complete contact
information (telephone numbers, mailing address, and email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (i.e., CDC, National Institutes of
Health, Food and Drug Administration, etc.).
Nominations may be submitted directly by the individual seeking
nomination or by the person/organization recommending the candidate.
CDC and HRSA will collect and retain nominations received for up to two
years to create a pool of potential CHAC nominees.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07997 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 17, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.